# Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular Immunity

> **NCT05458440** · NA · RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 32 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **OTHER:** Generation of a biobank allowing the cryopreservation of leucocytes from COVID19 convalescent donors

## Key facts

- **NCT ID:** NCT05458440
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2025-12-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05458440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05458440, "Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular Immunity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05458440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*